Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604457200 on October 24, 2006

J. Biol. Chem., Vol. 282, Issue 1, 208-215, January 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/1/208    most recent
M604457200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tenca, P.
Right arrow Articles by Santocanale, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tenca, P.
Right arrow Articles by Santocanale, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cdc7 Is an Active Kinase in Human Cancer Cells Undergoing Replication Stress*Formula

Pierluigi Tenca, Deborah Brotherton1, Alessia Montagnoli, Sonia Rainoldi, Clara Albanese, and Corrado Santocanale2

From the Department of Cell Biology, Nerviano Medical Sciences-Oncology, Via Pasteur 10, 20014 Nerviano, Italy

Cdc7 kinase promotes and regulates DNA replication in eukaryotic organisms. Multiple mechanisms modulating kinase activity in response to DNA replication stress have been reported, supporting the opposing notions that Cdc7 either plays an active role under these conditions or, conversely, is a final target inactivated by a checkpoint response. We have developed new immnunological reagents to study the properties of human Cdc7 kinase in cells challenged with the ribonucleotide reductase inhibitor hydroxyurea or with the DNA topoisomerase II inhibitor etoposide. We show that Cdc7·Dbf4 and Cdc7·Drf1 complexes are stable and active in multiple cell lines upon drug treatment, with Cdc7·Dbf4 accumulating on chromatin-enriched fractions. Cdc7 depletion by small interfering RNA in hydroxyurea and etoposide impairs hyper-phosphorylation of Mcm2 at specific Cdc7-dependent phosphorylation sites and drug-induced hyper-phosphorylation of chromatin-bound Mcm4. Furthermore, sustained inhibition of Cdc7 in the presence of these drugs increases cell death supporting the notion that the Cdc7 kinase plays a role in maintaining cell viability during replication stress.


Received for publication, May 10, 2006 , and in revised form, October 5, 2006.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S5.

1 Current address: Chroma Therapeutics, 93 Milton Park, Abingdon OX14 5RY, United Kingdom.

2 To whom correspondence should be addressed. Tel.: 390331581145; Fax: 390331581374; E-mail: corrado.santocanale{at}nervianoms.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
S. J. Szyjka, J. G. Aparicio, C. J. Viggiani, S. Knott, W. Xu, S. Tavare, and O. M. Aparicio
Rad53 regulates replication fork restart after DNA damage in Saccharomyces cerevisiae
Genes & Dev., July 15, 2008; 22(14): 1906 - 1920.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Nambiar, A. Mirmohammadsadegh, M. Hassan, R. Mota, A. Marini, A. Alaoui, A. Tannapfel, J. H. Hegemann, and U. R. Hengge
Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance
Carcinogenesis, December 1, 2007; 28(12): 2501 - 2510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. P. Heffernan, K. Unsal-Kacmaz, A. N. Heinloth, D. A. Simpson, R. S. Paules, A. Sancar, M. Cordeiro-Stone, and W. K. Kaufmann
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
J. Biol. Chem., March 30, 2007; 282(13): 9458 - 9468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement